Harmony Biosciences Holdings, Inc. stock rating and score history
All changes in ratings, performance and outlook tracked over time.
Harmony Biosciences Holdings, Inc. stock price, chart patterns and momentum
Recent price movements, trend behaviour and momentum signals based on real-time market data.
What does Harmony Biosciences Holdings, Inc. do? Business model and key facts
Get the full picture of Harmony Biosciences Holdings, Inc.: what it builds, where it operates, and how it makes money.
Sector: Healthcare
Industry: Biotechnology
Employees (FY): 268
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is based in Plymouth Meeting, Pennsylvania.
Stocks related to Harmony Biosciences Holdings, Inc.
Selected based on industry alignment and relative market positioning.
Events and news impacting Harmony Biosciences Holdings, Inc. stock
Earnings, coporate decisions and industry developments that can affect the share price.
Harmony Biosciences Holdings, Inc. fundamentals and technical analysis
Financial fundamentals and technicals signals combined to access stability, momentum and market direction.
